Sunteți pe pagina 1din 1

GOVT OF N.C.T. OF DELHI: DRUGS CONTROL DEPARTMENT F-17, 4TH FLOOR, KARKARDOOMA, DELHI-110032.

CERTIFICATE OF PHARMACEUTICAL PRODUCT1 This Certificate conforms to the format recommended by the World Health Organization (general Instructions and explanatory notes attached) No. of Certificate Valid Up to Exporting (certifying) country Importing (Requesting) country 1. 1.1 Name and dosage form of product Active ingredient(s)2 and amount(s) per unit Dose3. : WHO GMP/1615/12/1 : Two years from date of issue : India : Nigeria (As per annexure A) : LV- SIN : Composition: Levofloxacin 500mg 2B1 2B.2 Applicant for certificate (name and address) Status of applicant: a/b/c (key in appropriate category as defined In note 8) : NOT APPLICABLE : NOT APPLICABLE : NOT APPLICABLE

2B.2.1 For categories b and c, the name and the address of the manufacturer producing the dosage form are:9

2B.3
2B.4 : YES : YES 3.

Why is marketing authorization lacking? Not required/not Requested/Under consideration /refused (key in as appropriate)
Remarks;13 Does the certifying authority arrange for periodic inspection of the manufacturing plant in which the dosage form is produced? Yes/no/not applicable (key in as appropriate) If no or not applicable, proceed to question 4

: NOT APPLICABLE

For complete qualitative composition including excipients, see attached.4 1.2 1.3 Is this product licensed to be placed on the market for use in the exporting Country?5 Yes/No (key in as appropriate) Is this product actually on the market in the exporting country?5 Yes/No/Unknown (Key in as appropriate)

: YES

If the answer to 1.2 is yes, continue with section 2A and omit section 2B. If the answer to 1.2 is no, omit section 2A and continue with section 2B6 2A1 2A2 Number of product licence7 and date of issue Product License holder address) (Name and : : 1615 on Form 25 Dated 31.07.1997 Abyss Pharma Pvt Ltd B-121 Phase I Mayapuri, Indl Area New Delhi- 110064 (key : : a NOT APPLICABLE : NO

3.1 3.2 3.3

Periodicity of routine inspections (years) Has the manufacture of this type of dosage form been inspected? Yes/no (key in as appropriate) Do the facilities and operations conform to GMP as recommended by the World Health Organization?15 Yes/no/not applicable14(key in as appropriate) Does the information submitted by the applicant satisfy the certifying authority on all aspects of the manufacture of the product?16 yes/no (key in as appropriate)

: ONCE IN TWO YEARS : YES : YES

2A3 2A3.1 2A4 2A.5

Status of product License holder.8 a/b/c appropriate category as defined in note 8)

4.

: NOT APPLICABLE

For categories b and c, the name and the address of the manufacturer producing the dosage form are.9

If no, explain: Address of certifying authority: Licensing Authority, Govt. of N.C.T. of Delhi, Drugs Control Department, F-17, 4th Floor, Karkardooma, Dehi 110032

Is summary basis of approval appended?10 yes/no (key in as appropriate)

Is the attached, officially approved product information complete : NOT PROVIDED and consonance with the license?11 yes/no/not approved (key in as appropriate). Applicant for certificate if different from License holder (name and address).12 : NOT APPLICABLE

Telephone Number:

22392702
A. P. Singh

Fax Number:

22393707

2A.6

Name of authorized person Signature: Stamp and Date:

Licensing Authority